Navigation Links
Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
Date:5/7/2009

NEW BRUNSWICK, N.J., May 7 /PRNewswire-FirstCall/ -- In letters to Senate Special Committee on Aging Chairman Herb Kohl (D-WI) and Senate Finance Committee Ranking Member Charles Grassley (R-IA), Johnson & Johnson today announced its support for the Physician Payments Sunshine Act of 2009 (S. 301). The company also committed to begin voluntarily disclosing payments made to physicians by its U.S. pharmaceutical, medical device and diagnostics companies.

"We are in favor of greater transparency regarding the relationships between healthcare companies and physicians," said Johnson & Johnson chairman and CEO William C. Weldon. "We continue to believe such transparency is in the best interest of patients, payers, other stakeholders in healthcare and the industry itself."

The U.S. pharmaceutical companies of Johnson & Johnson will begin voluntarily providing information about the payments that they make to physicians on their respective web sites beginning in the first half of 2010. Reporting will be expanded to include the company's U.S. medical devices and diagnostics units and will reflect the general provisions of the Physician Payment Sunshine Act by June 30, 2011.

"Since we first introduced the bill, there has been a groundswell of support from every corner. I wholeheartedly welcome the endorsement from Johnson & Johnson. Patients want to know that they can fully trust the relationship they have with their doctor. I am confident this legislation will pass during the 111th Congress," said Senator Herb Kohl (D-WI), Chairman of the Special committee on Aging.

Weldon said, "Greater transparency will enhance trust and recognition that collaborations between pharmaceutical and device manufacturers and physicians lead to important medical advances that save lives. I commend Senators Kohl and Grassley for a constructive exchange of ideas and look forward to continuing to work wi
'/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients ... to a recent online survey* sponsored by Mission Pharmacal ... the National Osteoporosis Foundation online support community, revealed that ... medication that comes in a form other than a ...
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... CITY, Feb. 21, 2012 Genomma Lab Internacional, S.A.B. de ... a non-binding proposal to acquire all of the outstanding shares ... ) common stock for $16.60 dollars per share in cash. ... including Prestige,s net debt. Genomma,s all-cash proposal ...
... Corporation (NYSE: SHP ) ("ShangPharma" or the ... development outsourcing company, today announced that it will attend ... in Boston, Massachusetts from March 5-7, 2012. ... Relations of ShangPharma, will present at the conference and ...
Cached Medicine Technology:Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 2Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 3Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 4Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 5
(Date:4/18/2014)... scientists could lead to potential new treatments for breaking ... , Fibrosis, or scarring, is a hallmark of ... lungs can lead to serious organ damage and, in ... options centers on findings made by Swati Bhattacharyya, PhD, ... that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... identified new pain relief targets that could be ... researchers at King,s College London made the discovery ... the periphery of the body. , Dr Marzia ... mechanisms underlying pain generation and our findings could ... effects." , One potential side effect of some ...
(Date:4/17/2014)... the University of California, San Diego School of Medicine ... have suffered a recent major loss are more likely ... , The study is published in this month,s issue ... , Because compassionate behaviors are associated with better health ... insights into ways to improve the outcomes of individuals ...
(Date:4/17/2014)... University synthetic biology team has created a new ... therapeutics that could travel the body and selectively ... Engineering cell-based, biological devices that monitor and modify ... synthetic biology. However, no existing technology enabled bioengineers ... physiological state and respond in a customized fashion. ...
(Date:4/17/2014)... The cause of neuronal death in Parkinson,s disease is ... may be mistaken for foreign invaders and killed by ... autoimmune diseases like type I diabetes, celiac disease, and ... published April 16, 2014, in Nature Communications . ... in Parkinson,s disease; but if true, it could lead ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2
... , ... ... ... ...
... are beginning to find out why people with Parkinson,s ... harder to recognize expressions of emotion in other people,s ... American Psychological Association. One of the studies raises ... treatment for patients who no longer respond to medication, ...
... ... Innovative Set of Sales and Lead Cycle Management Technology , ... (PRWEB) March 3, 2010 -- References-Online, pioneer and leader in ... RO|Innovation (ROI). The name and brand identity shift reflects the expanded suite of ...
... , ... ... ... ...
... ... ... , ... , , ...
... already shown to be effective in breast cancer packs an ... have a specific genetic mutation, a study at UCLA,s Jonsson ... Tykerb when given together proved to significantly inhibit tumor growth ... a mutation that results in an aggressive form of the ...
Cached Medicine News:Health News:AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 2Health News:AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 3Health News:Parkinson's disease makes it harder to figure out how other people feel 2Health News:Parkinson's disease makes it harder to figure out how other people feel 3Health News:Embodying an Evolving Solution Set, References-Online is Now RO|Innovation 2Health News:Embodying an Evolving Solution Set, References-Online is Now RO|Innovation 3Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 2Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 3Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 4Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 5Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 6Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 7Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 8Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 9Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 10Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 11Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 12Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 13Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 14Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 15Health News:'Sharing Miracles' Television Program to Feature Legendary College Football Coach Bobby Bowden 16Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 2Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 3Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 4Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 5Health News:Herceptin and Tykerb effective against a subset of gastric cancers 2Health News:Herceptin and Tykerb effective against a subset of gastric cancers 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: